Literature DB >> 29753404

Cardiovascular Disease After Kidney Transplant.

Nitesh N Rao1, P Toby Coates2.   

Abstract

Renal transplantation is the preferred treatment for patients with end-stage kidney disease. However, despite successful kidney transplantation, cardiovascular disease (CVD) remains one of the major causes of patient death and hence graft loss. The antecedents of this increased risk reside within the development of end-stage kidney disease and dialysis. Risk factors for the development of CVD include diabetes, hypertension, and dyslipidemia. Other transplant-specific factors include the presence of a patent arteriovenous fistula and immunosuppressive therapy. Efforts to modify these factors should be strongly encouraged to improve long-term outcomes of transplant patients and reduce death from CVD in this at-risk patient population.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiovascular disease; kidney transplantation

Mesh:

Year:  2018        PMID: 29753404     DOI: 10.1016/j.semnephrol.2018.02.008

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  11 in total

Review 1.  Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.

Authors:  Maja Cigrovski Berkovic; Lucija Virovic-Jukic; Ines Bilic-Curcic; Anna Mrzljak
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

2.  Costs of Long-Term Post-Transplantation Care in Kidney Transplant Recipients.

Authors:  Anna Łabuś; Mariusz Niemczyk; Łukasz Czyżewski; Magda Fliszkiewicz; Andrzej Kulesza; Krzysztof Mucha; Leszek Pączek
Journal:  Ann Transplant       Date:  2019-05-07       Impact factor: 1.530

3.  Peripheral blood lymphocyte subsets change after steroid withdrawal in renal allograft recipients: a prospective study.

Authors:  Laura Llinàs-Mallol; Dolores Redondo-Pachón; María José Pérez-Sáez; Dàlia Raïch-Regué; Marisa Mir; José Yélamos; Miguel López-Botet; Julio Pascual; Marta Crespo
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

Review 4.  Non-immunological complications following kidney transplantation.

Authors:  Abraham Cohen-Bucay; Craig E Gordon; Jean M Francis
Journal:  F1000Res       Date:  2019-02-18

5.  Multimodality Tachycardia-Induced Stress Testing Predicts a Low-Risk Group for Early Cardiovascular Mortality After Renal Transplantation.

Authors:  Nicholas J Montarello; Tania Salehi; Alex P Bate; Anthony D Pisaniello; Philip A Clayton; Karen S L Teo; Matthew I Worthley; Patrick T Coates
Journal:  Kidney Int Rep       Date:  2020-10-22

6.  Microalbuminuria After Kidney Transplantation Predicts Cardiovascular Morbidity.

Authors:  Dana Bielopolski; Ruth Rahamimov; Boris Zingerman; Avry Chagnac; Limor Azulay-Gitter; Benaya Rozen Zvi
Journal:  Front Med (Lausanne)       Date:  2021-04-12

7.  Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation.

Authors:  Agnieszka Szymańska; Krzysztof Mucha; Maciej Kosieradzki; Sławomir Nazarewski; Leszek Pączek; Bartosz Foroncewicz
Journal:  Int J Environ Res Public Health       Date:  2022-02-11       Impact factor: 3.390

8.  Left ventricular rotational abnormalities following successful kidney transplantation-insights from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

Authors:  Bernadett Borda; Árpád Kormányos; Péter Domsik; Anita Kalapos; Csaba Lengyel; Nóra Ambrus; György Lázár; Tamás Forster; Attila Nemes
Journal:  Quant Imaging Med Surg       Date:  2018-12

9.  CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients.

Authors:  Yilei Yang; Xin Huang; Yinping Shi; Rui Yang; Haiyan Shi; Xinmei Yang; Guoxiang Hao; Yi Zheng; Jianning Wang; Lequn Su; Yan Li; Wei Zhao
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

10.  Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.

Authors:  Paul N Harden; David S Game; Birgit Sawitzki; Jeroen B Van der Net; Joanna Hester; Andrew Bushell; Fadi Issa; Matthew O Brook; Alaa Alzhrani; Stephan Schlickeiser; Cristiano Scotta; William Petchey; Mathias Streitz; Gilles Blancho; Quizhi Tang; James Markmann; Robert I Lechler; Ian S D Roberts; Peter J Friend; Rachel Hilton; Edward K Geissler; Kathryn J Wood; Giovanna Lombardi
Journal:  Am J Transplant       Date:  2021-02-02       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.